Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...
The Evelyn F. McKnight Brain Institute at the University of Alabama at Birmingham (UAB) was established in 2004 by a gift from the McKnight Brain Research Foundation to support research in cognitive ...
the new information indicates that attempting to solve memory loss through solutions that only affect the brain could be futile. "This discovery opens new doors for understanding how memory works ...
Drugs known as cholinesterase inhibitors can ease cognitive symptoms in Alzheimer’s disease, including memory loss, confusion, altered thought processes, and judgment problems. They improve ...
Sleep helps memory in two ways ... or neurological conditions A medication evaluation to find out if any medications or supplements you take are causing side effects that interfere with sleep ...
Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug ...